218 related articles for article (PubMed ID: 34216572)
41. Thiazide and thiazide-like diuretics are associated with improved cardiovascular and renal outcomes in patients with chronic kidney disease.
Lin HY; Chang YH; Wang YT; Liang PI; Hung CC; Chang JM; Dai DF; Lin CS; Chang KT
Ann Acad Med Singap; 2023 Oct; 52(10):510-521. PubMed ID: 38920202
[TBL] [Abstract][Full Text] [Related]
42. Coronary revascularisation in patients with chronic kidney disease and end-stage renal disease: A meta-analysis.
Li X; Xiao F; Zhang S
Int J Clin Pract; 2021 Nov; 75(11):e14506. PubMed ID: 34117687
[TBL] [Abstract][Full Text] [Related]
43. Effects of Prevalent and Incident Atrial Fibrillation on Renal Outcome, Cardiovascular Events, and Mortality in Patients with Chronic Kidney Disease.
Hsu HH; Kor CT; Hsieh YP; Chiu PF
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31484322
[TBL] [Abstract][Full Text] [Related]
44. Thrombolysis in acute ischaemic stroke patients with chronic kidney disease.
Pana TA; Quinn J; Mohamed MO; Mamas MA; Myint PK
Acta Neurol Scand; 2021 Dec; 144(6):669-679. PubMed ID: 34328648
[TBL] [Abstract][Full Text] [Related]
45. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
Steinberg BA; Kim S; Piccini JP; Fonarow GC; Lopes RD; Thomas L; Ezekowitz MD; Ansell J; Kowey P; Singer DE; Gersh B; Mahaffey KW; Hylek E; Go AS; Chang P; Peterson ED;
Circulation; 2013 Aug; 128(7):721-8. PubMed ID: 23861512
[TBL] [Abstract][Full Text] [Related]
46. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
[TBL] [Abstract][Full Text] [Related]
47. Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
O'Neal WT; Tanner RM; Efird JT; Baber U; Alonso A; Howard VJ; Howard G; Muntner P; Soliman EZ
Int J Cardiol; 2015 Apr; 185():219-23. PubMed ID: 25797681
[TBL] [Abstract][Full Text] [Related]
48. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
[TBL] [Abstract][Full Text] [Related]
49. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
[TBL] [Abstract][Full Text] [Related]
50. Outcomes in Patients With Chronic Kidney Disease and End-stage Renal Disease and Durable Left Ventricular Assist Device: Insights From the United States Renal Data System Database.
Dalia T; Chan WC; Sauer AJ; Ranka S; Goyal A; Mastoris I; Pothuru S; Abicht T; Danter M; Vidic A; Gupta K; Tedford RJ; Cowger J; Fang JC; Shah Z
J Card Fail; 2022 Nov; 28(11):1604-1614. PubMed ID: 35470059
[TBL] [Abstract][Full Text] [Related]
51. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
Rhee CM; Kovesdy CP; You AS; Sim JJ; Soohoo M; Streja E; Molnar MZ; Amin AN; Abbott K; Nguyen DV; Kalantar-Zadeh K
Am J Kidney Dis; 2018 Nov; 72(5):701-710. PubMed ID: 30037725
[TBL] [Abstract][Full Text] [Related]
52. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
[TBL] [Abstract][Full Text] [Related]
53. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
54. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.
Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR
Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744
[TBL] [Abstract][Full Text] [Related]
55. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis.
Thongprayoon C; Cheungpasitporn W; Phatharacharukul P; Edmonds PJ; Kaewpoowat Q; Mahaparn P; Bruminhent J; Erickson SB
Int J Clin Pract; 2015 Sep; 69(9):998-1006. PubMed ID: 26147121
[TBL] [Abstract][Full Text] [Related]
56. Is there association between changes in eGFR value and the risk of permanent type of atrial fibrillation? Analysis of valvular and non-valvular atrial fibrillation population.
Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
Kidney Blood Press Res; 2014; 39(6):600-8. PubMed ID: 25531163
[TBL] [Abstract][Full Text] [Related]
57. Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis.
Hsiung JT; Kleine CE; Naderi N; Park C; Soohoo M; Moradi H; Rhee CM; Obi Y; Kopple JD; Kovesdy CP; Kalantar-Zadeh K; Streja E
J Ren Nutr; 2019 Jul; 29(4):310-321. PubMed ID: 30642656
[TBL] [Abstract][Full Text] [Related]
58. The Effect of Chronic Kidney Disease or End-stage Kidney Disease on Perioperative Outcomes and Healthcare Utilization in Patients Undergoing Bariatric Surgery.
Lee Y; Tessier L; Jong A; Padoan A; Samarasinghe Y; McKechnie T; Molnar AO; Walsh M; Doumouras A; Dang J; Kroh M; Hong D
Obes Surg; 2023 May; 33(5):1476-1485. PubMed ID: 36922464
[TBL] [Abstract][Full Text] [Related]
59. Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019.
Zhang L; Steckman DA; Adelstein EC; Schulman-Marcus J; Loka A; Mathew RO; Venditti FJ; Sidhu MS
Cardiovasc Drugs Ther; 2019 Aug; 33(4):481-488. PubMed ID: 31165356
[TBL] [Abstract][Full Text] [Related]
60. Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018).
Minhas AMK; Bhopalwala HM; Dewaswala N; Ijaz SH; Khan MS; Khan MZ; Dani SS; Warraich HJ; Greene SJ; Edmonston DL; Lopez RD; Virani SS; Bhopalwala A; Fudim M
Am J Cardiol; 2023 Sep; 202():41-49. PubMed ID: 37419025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
